Press "Enter" to skip to content

Merck bolsters animal health unit with $2.4 billion Antelliq purchase

The move affirms the drugmaker’s commitment to the business, which Wall Street analysts have long seen value in separating just as rival drugmakers Eli Lilly and Co and Pfizer Inc did.

Original source:

Also Read:   Around 75% pharma units operational in Gujarat: FDCA